NINDS


Also found in: Acronyms.

National Institute of Neurological Disorders and Stroke

 
an institute of the national institutes of health whose mission is to reduce the burden of neurological diseases by supporting and conducting research (both basic and clinical) on the normal and diseased nervous system, fostering the training of investigators in the neurosciences, and seeking better understanding, diagnosis, treatment, and prevention of neurological disorders.

NINDS

Neurology A multicenter, double blinded, randomized trial–National Institute of Neurological Disorders and Stroke which evaluated the effects of tPA therapy in Pts with stroke. See Thrombolytic therapy, tPA.

National Institute of Neurological Disorders and Stroke

,

NINDS

An agency that conducts research on nervous system disorders, including Alzheimer's disease, Parkinson's disease, and stroke, that occur with greater frequency in the elderly.
References in periodicals archive ?
This work was supported by the NINDS (NS091618-01) and the Department of Defense (W81XWH-13-2-0095).
In the NINDS studies, the protocols dictated that treatment start within 3 hours of onset of symptoms, and within 90 min for half the patients.
What ethical, legal, and social issues are likely to arise from advances in basic and clinical neuroscience over the next 15 years, for which the NINDS should be prepared?
Two sections of the homepage allow researchers to find out about funding opportunities Under the Funding Opportunities header, visitors can retrieve lists of NINDS opportunities either for the last 60 days or all current opportunities.
Thirteen new genetic markers, 11 this year alone, have been identified since the striking discovery six years ago of the first marker for the HD gene by NINDS grantee Dr.
a program director in the NINDS Office of Translational Research and the lead contact for the Blueprint Neurotherapeutics Network.
This study was supported by the Intramural Research Programs at the NINDS and the National Cancer Institute, the National Multiple Sclerosis Society, and the Conrad N.
Kovach, the lead presenter and President and CEO of Lixte, said that the company and SNB, NINDS are continuing to develop LB-1 and other compounds for the treatment of human brain cancers.
The National Institute of Neurological Disorders and Stroke (NINDS) has set aside a total of $2,250,000, in addition to funds available for applications sent in response to this PA that score within the NINDS payline (see NINDS Funding Strategy http://www.
Before the creation of NINDS, the federal government had invested about $14,000 in MS-related research.
4 million and was awarded under the NINDS Fast-Track Small Business Innovative Research Cooperative Program in Translational Research that supports the identification and preclinical testing of new therapeutics for neurological disorders.
NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.